Following the short-term negative impact of the\u00a0COVID-19\u00a0pandemic on the Asia Pacific\u00a0PV\u00a0device market, the high prevalence of\u00a0PAD\u00a0in the region, an expanding patient population, growth in endovascular procedure volumes, and rising adoption of premium-priced devices such as\u00a0DCBs and\u00a0DES\u00a0will support continued growth in the Asia Pacific\u00a0PV\u00a0device market; however, cost constraints in the region’s publicly funded healthcare systems and limited reimbursement continue to hinder adoption of premium-priced devices and limit the pace of revenue expansion.<\/p>\n
This Medtech 360 Report provides high-level market metrics for\u00a0PV\u00a0devices in Asia Pacific, including country-level data for major countries and aggregate data for the rest of Asia Pacific from 2019 through 2031.<\/p>\n","protected":false},"template":"","class_list":["post-385831","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-peripheral-vascular-devices","medtech-geography-asia-pacific","medtech-date-976"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/385831","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/385831\/revisions"}],"predecessor-version":[{"id":387341,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/385831\/revisions\/387341"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=385831"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}